Butylphthalide：Treating Stroke Nerve Damage

Butylphthalide：Treating Stroke Nerve Damage

Product
Butylphthalide：Treating Stroke Nerve Damage
Butylphthalide：Treating Stroke Nerve Damage

Information

CAS：6066-49-5 Molecular formula：C12H14O2 Formula weight：190.24 Appearance: Transparent to light yellow clarified oily liquid (API); Transparent liquid (injection) Indication： Improve the neurological deficits in patients with acute ischemic stroke. Improve the blood circulation of the brain, especially the micro-circulation in the ischemic area, has a relatively strong improvement effect. Protects neuronal mitochondrial function, improves energy metabolism and inhibits apoptosis.
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
China
Jilin Qijian Bio-pharmaceutical Co., LtdEstablished in 2005, Jilin Qijian Bio-Pharmaceutical Co., Ltd. is a cGMP pharmaceutical company and specialized in R&D, production and sales of API and FDF. Qijian is a High Tech Enterprise based in Changchun City, Jilin Province, China, and registered in US FDA, also filed in US FDA DMF. As manufacturer and global exporter, Qijian main products: Recombinant human growth hormone Somatropin (r-hGH ) （China GMP） Butylphthalide（China GMP） Ademetionine 1,4-Butanedisulfonate (SAM) Monosialotetrahexosyl-ganglioside Sodium (GM1)

Log in

See all the content and easy-to-use features by logging in or registering!